In a study conducted by Brock et al., it was demonstrated that increased levels of interleukin 6 (Il-6), which is engaged in PAH development, caused an upregulation in the expression of the miRNA cluster miR-17/92 [54]. Here, IL6 is linked to pulmonary arterial hypertension.